Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a research report report published on Sunday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently weighed in on the stock. William Blair reaffirmed an “outperform” rating on shares of Tenax Therapeutics […]

Leave a Reply

Your email address will not be published.

Previous post Citigroup Cuts Huntsman (NYSE:HUN) Price Target to $14.00
Next post Recon Technology (NASDAQ:RCON) Now Covered by Analysts at StockNews.com